Demogtaphic data of the Greek haemophiha A and B population for the penod 1972-1993 were analyzed Pievalence at buth includmg known not-registeied patients was calculated at 23 l pei 100,000 male births However, the obseived prevalence m 1993 was only 61% of the expected Smce 1975 the propoition of mild cases had sigmficantly mcreased Adjusted by age, seventy and HIV Status leproductive fitness of haemophihacs was 062 Overall moitahty was 26 times highei than in the geneial population, but 7 9 times among patients with seveie haemophiha and 16 4 among HIV(+) haemophihacs Fifty out of 78 deaths occuired among HIV(+) patients and 28 of these were caused by AIDS Inhibitoi patients did not show excess moitahty due to bleeding Cancei mortahty was equal to noimal, but the number of deaths fiom ischaemic heart disease was 0 25 of the expected Risk of death due to cerebial haemonhage was 3 8 times highei m HIV(+) haemophihacs than m HIV (-) 
Introduction
The Haemophilia Treatment Centie of Laikon Hospital (HTCLH), Athens, prov:des care for 72% of Greek haemophiha A and 81% of Greek haemophiha B patients (1) and is one of the largest Eiuopean haemophiha centtes This survey with infoimation about 531 patients and their families covers a twenty-one-yeai penod and has the aim to estimate the pievalence of the disordei, the lepioductive fitness of haemophihacs and the mortahty and causes of death ot this group In the moitahty figures, the impact of HIV mfection is de scnbed
It is important to note that since 1960 Greek haemophihacs have started to be treated systematically with fiesh-frozen plasma Lyophihzed ciyoprecipitate of national ongm was intioduced m 1969 and PPSB m 1973 Factoi VIII and later Factoi IX concentrates weie mitially impoited only foi majoi suigeiy and smce 1980-81 foi loutine use In Septembei 1985 virus mactivated concentiates leplaced all previous pioducts Inteimediate and high punty concentiates äs well äs FVIII punfied by monoclonal antibody techmques aie now used foi Substitution therapy Dunng the last 5 yeais of the study the mean FVIII consumption was 12,500 IU annually per haemophihac (24,000 IU foi actively treated patients) Home treatment staited eveismce 1972 and it was spiead to all patients that would benefit from it durmg the study Coirespondence to Di Titica Mandalaki, 2nd Reg Blood Transfusion Centie, Haemophilia Treatment Centre, Laikon General Hospital, 17 Aghiou Thoma Stieet, 11527 Athens, Gieece -FAX Nutnbei +30 l 7779774 penod Fmally, it is noteworthy that piophylactic treatment has never been used routmely m oui centre (1) The observed increasing pievalence of haemophiha, the mcieased patients aveiage age and the changes in the death causes are factors that leflect the achievements of the last decades m the management of haemophiha and would be helpful if taken under consideration for planmng of future haemophiha care
Patients and Methods

Pievalenie
In estimatmg the pievalence at birth one has to account for underestimatmg because of dealhs and delayed diagnosis (2) A fnst approach is to piepare a cuive of the actual pievalence (number of hvmg patients/number of living males) in all age gioups, which will show a plateau m the first decades of adult hood This will yield a fair estimate if excess moitahty is not too high, but will still be an undeiestimate Heie we attempted a direct approach we searched to count all patients bom m the penod 1952-1976, and divided the final numbei by all males bom m this penod m Gieece This penod, with patients now lang mg m age fiom 15 to 40 (if still ahve) was chosen to mimmize the effects of delays m diagnosis and registiation befoie age 15, and of high excess mortahty m oldei patients Fnst, we made a table of all oui legisteied patients (dead and ahve) born in this penod Subsequently we conducted family studies in 148 pedigrees to identiiy umegisteied patients (dead or ahve) which showed that our legisüy had a completeness of 85% in haemophiha A and 81% m haemophiha B In addition, we know that 28% of haemophiha A, and 19% of haemophiha B patients aie legisteied m other cenües Fmally, with these figuies we extia polated fiom the patients legisteied in our centre, to all patients bom m Greece between 1952 and 1976 by a piopoitional extension The estimation of the obseived prevalence was based on the same method, apart from the fact that m the table we mcluded only patients ahve m the beginnmg of 1993
Fitness
Data for 318 patients bom m the penod 1931-1970 were used for the estimation of the lepioductive fitness of haemophihacs The numbei of their offspnng until 31 12 92 denved from family studies Haemophihacs who died befoie leachmg genetic matunty (under age 15) were mcluded m the final fit ness calculation smce they represent haemophilic genes lost All patients were divided in thiee gioups accoidmg to seventy and in foui subgroups accoidmg to the decade of then bn th The mean number of childi en of the patients m each age gioup was compared to the expected number foi that age group based on figuies foi the geneial male population (3) The ratio of the obseived numbei of childien summed over all age gioups, and of the expected numbei summed over all age gioups is the age-standardized fitness The observed number of children was adjusted for HlV-status and seventy pnor to this companson, to allow for mcomplete data in some of the patients seen less frequently [i e HIV(-) pa tients, mild haemophiha] and not mcluded m the study Complete data on fami ly size weie available foi 82% of our centie's patients Obviously, for vanous leasons HIV Status and seventy affect fitness
Mortahty, Life Expectancy, Causes ofDeath
The follow-up covers the penod from 1-1-1972 to 31-3-1993 Sixty-two patients with mild haemophiha (mean FVIII C approximately 11 lU/dl) onginatmg from the village Aiani of Macedonia and sharmg the same mutation (4) formed a special category The patient-yeai method was used for the calculation of Standardized Mortahty Ratios (SMR), which compare the observed to the expected number of deaths, based on the population moitahty rates The expected mortahty was adjusted for age, sex and calendar penod The calculation of confidence mtervals was based on a Poisson distnbution Smce for several reasons mfant moitahty in haemophihacs may be underestimated (5, 6) we decided to exclude mfant mortahty m both patients and population figures Therefore, when registration year was the year of birth, entry m the study group was one yeai later The eight age groups used weie 1-19, 20-29, , 70-79 and over 80 years old The same calculations were made for the group of HIV(+) patients startmg from the approximate mean seroconversion date (1-1-1983) The causes of death were m almost all cases certified by HTCLH physicians Autopsies were generally not perfoimed Cause-specific mortahty foi deaths due to cancer and ischaemic heart disease were calculated with cause-specific population mortahty lates Fmally, aftei an initial obseivation of excess moitahty due to cerebi al haemoi rhage of HIV(+) patients over HIV(-), we estimated the mcidence of fatal cerebral bleedmg m both groups adjusted foi age and seventy Patient-yeais for HIV(+) and HIV(-) Status were calculated usmg 1-1-1983 äs the seroconversion date for HIV(+) patients Obviously, these patients contnbuted patient-time to both HIV(-) patient-yeais (befoie 1-1-83) and HIV(+) patient-yeais (aftei 1-1-83) A Poisson legiession model was used to estimate the mcidence late ratio foi fatal ceiebral bleedmg m HIV(+) and HIV(-) Status adjusted for age and seventy The results were expiessed äs täte ratios, relative for each variable to the lowest (refeience) categoiy
Definition!
Patients were grouped by seventy accoidmg to FVIII C 01 FIX C levels, seveie clottmg activity <1 lU/dl, moderate clottmg activity 1-5 lU/dl, mild clottmg activity 5-25 lU/dl Haemophiha B Leiden patients weie consideied äs mild cases Von Willebrand disease was excluded by appiopnate testmg Coagulation measuiements weie perfoimed by standaid techniques We The prevalence at birth is calculated by the number of males born ahve m Greece between 1952 and 1976 The total prevalence pei 100,000 male births by seventy is severe 9 8 (42%), moderate 3 4 (15%) and mild 9 9 (43%) The observed prevalence is calculated accordmg to the Greek male population m the 1991 census The total prevalence per 100,000 males by seventy is severe 4 6 (33%), moderate 2 7 (19%) and mild 6 7 (48%) Table 2 Reproductive fitness of haemophiha A & B patients by penod of birth and seventy consideied äs legisteied only male patienls with a known vital Status mcluding dates ofbnth and death, type and seventy of haemophiha In this way about 5% of patients weic excluded fiom the study foi mcomplete data
Results
At l 3-93 theie weie 707 Greek haemophilia patients on a total population of 5 05 imlhon Gieek males, i e obseived pievalence was 14 0 pei 100,000 males -12 0 in haemophiha A, 2 0 in haemophiha B (Table 1 ) Among these patients 619 weie legisteied (453 m oui centie and 166 elsewheie) and 88 (12%) weie known not legistered patients It also follows that observed pievalence of seveie haemophiha was one out of 21,500 males The oveiall pievalence at buth was 23 l pei 100,000 male bnths, 65% highei than the obseived prevalence This imphes that one out of 5,200 males is boin with haemophiha A and one out of 27,000 males with haemophiha B Infoimation about lepioductive fitness toi patients boin befoie 1970 is given m Table 2 The '62 patients wilh mild haemophilia had a common ancestoi oiigmating fiom the village Aiam öl Macedoma Foui patienls aie haemophilia B Leiden 'HIV beropOMtivity is much lowei among haemophiha B patients (8%) and diffeis consideiably by seventy (seveie 62%, modeiate 28%, mild 8%) 3 No haemophiha B patient developed mhibitoi and only 14 patients (3% of the haemophiha A population) out of 38 weie high lespondeis, i e developed non üansient mhibitois (anamnestic lesponse with tities ovei 10 BU/ml) Conceimng moitahty, we followed 531 individuals (the geneial cha lactenstics of that population are descnbed m Table 3 ) foi a total of 8641 peison-yeais We obseived 78 deaths (Table 4) , while 30 weie expected based on age and sex adjusted population lates [SMR 2 6 with 95% confidence mteivals (C l) of 2 l to 3 3] Moitahty was almost 8 times highei m patients with seveie haemophiha than m the general population and the majonty of deaths -54 -occuned among patients of this gioup On the contiaiy, patients with mild and modeiate haemo phiha did not expenence excess moitahty (SMR about 1) Moitahty was by fai the highest in HIV(+) haemophihacs aftei the mean date of mfection (SMR 16 4) Of the 78 deaths m oui cohoit, 50 occuned m HIV(+) patients [32% of the 156 HIV(+) patients had died] It should be emphasized that among HIV(-) patients with modei ate and mild hae mophiha we obseived no death undei the age of 48 and among the 62 patients oiigmating fiom the Aiam village only one patient had died The mean age of death of oui patients was 44, while m seveie haemo phiha it was 39 and m mild haemophiha 53 Life expectancy foi HIV(-) patients appeaied to be almost noimal
The most common cause of death among oui patients was AIDS (Table 5 ) Ceiebial haemonhage followed m fiequency and was the commonest cause among HIV(-) patients Othei types of bleedmg weie lesponsible foi only 8 deaths Among the 38 mhibitoi patients only one high lespondei died fiom bleedmg m 1983 Howevei, 7 moie patients of this gioup died due to vual diseases (five by AIDS, two by hvei diseases) SMR foi deaths due to mahgnancies was 0 83 with 95% C I of 0 3 to l 8 Only one patient died due to ischaemic heart disease mstead of foui expected Consequently, the SMR foi that cause was 025 with 95% CI of 00 toi 4 The moitahty by ceiebial haemonhage was found 5 0 times highei m HIV(+) than m HIV(-) haemophihacs, i e 8 m the 7210 patientyeais of the HIV(-) group and 8 in the 1431 patient yeats of the HIV(+) gioup The incidence of death by ceiebial bleedmg was almost the same -5 5 pei 1,000 patient yeais -in all thiee seventy gioups among HIV(+) haemophihacs, while in HIV(-) patients it vaned fiom 04m mild cases to l 6 in modeiate and seveie Smce the HIV(+) patients diffeied m seventy of haemophiha and age distnbution fiom the HIV(-) patients, we adjusted toi these vanables by multivanate Pois son legiession This showed that each increase in seventy (mild to modeiate, modeiate to seveie) doubled the nsk of death fiom ceiebial haemonhage (Table 6 ), while each 10-yeai inciease m age led to l 5 mcieased nsk Most impoitantly, aftei this coirection, the nsk of HIV(+) individuals still was 3 8 times äs high äs foi HIV(-) patients
Discussion
It is obvious that the lesults öf this study aie much colomed by HIV mfection The modeiate use ot impoited commercial concentiates on one hand and the peisistence m stiictly pioviding "on demand" substi tution theiapy on the other, have lesulted m a medium numbei of seio positive patients m Gieece (29%) compaied to Geimany (53%), France (50%) and United Kingdom (39%), wheie highei pievalences of HIV antibodies among haemophihacs have been obseived (7) (8) (9) , and to The Netheilands (17%), Belgium (4%) and Fmland (l 5%), where the piedommant use of plasma pioducts fiom local nonpaid donois (10, 11) explams the low numbei s of mfected patients Of couise, the peicen tages given aie not completely compaiable smce diffeient methods have been apphed foi the calculations A compauson of the piesent study with a lepoit foi the Gieek hae mophiha population m 1975 (12) shows a consideiable inciease in the obseived pievalence of haemophiha (140 veisus 86 pei 100,000 3 HI V (-) äs reference category males), but a shght reduction (from 5 l to 4 6) among severe patients, probably due to the AIDS epidemic and the satisfactory registry m this gioup, already by 1975 On the contraiy, the rapid growth of mild patients population (from 2 0 to 6 7) is a result of mcreased registry and reduced moitality Mild haemophihacs now represent almost half of the total number of patients compared to 23% m 1975 A similar develop ment was observed m Sweden (13) between 1960 and 1980 (fiom 35% to 54%) The total pievalence at birth (23 l per 100,000 male births), is dose to 20 6 calculated for the Dutch population (2) and to 17 8 re sulüng by apphcation of the plateau method to Swedish data (13) Oui estimation is shghtly higher, which may be explamed by our effoits to mclude known, not legistered patients by family studies, which was not attempted in the other studies Without this correction, our esümation becomes 19 5 per 100,000 The calculation of prevalence at buth requires exüapolations that will have müoduced some erroi It is hkely that, despite all effoits, some patients were not counted, e g those who were never diagnosed Therefoie, we still think this estimate to be a shght underestimate
If the sarae prevalence äs at birth was observed in each age group, the Greek haemophihc population, whtch is now estimated at 707 patients, would have consisted of 1161 mdividuals The deficit of 39% is higher than the leported fiom The Netheilands (22%) and Sweden (23%) (2,13) Several explanations may be offeied i) Even elementary haemophiha caie started to be provided in Greece later than the most Western Euiopean countnes, which may have led to higher deficit in older age groups because of early deaths u) Many patients are still not registered, which depnves them from specialist care m) Deaths due to AIDS (not tncluded in the previous studies) iv) Moie women in Greece tend to choose foi prenatal diagnosis and selective abortion than Dutch and Bntish women (2, 14) Greek women are more accustomed to the idea of "pregnancy termmation", because of the high pievalence of thalassaemia heterozygotes and the legalization of abortion ten yeais ago Generally, it seems that the deficit between obseived prevalence and pievalence at birth will not be elimmated m the Greek population (leading to a significant mcrease in the number of haemophihacs) so soon äs was foteseen for the Dutch haemophihacs (2) An additional reason foi that is the higher HIV(+) percentage, not so much äs a cause of a temporary mcreased excess moitality, but because of its effects m the reproductivity of our population, which may reduce on a long term basis the number of obligate cainers Conclusively, no mciease of haemophiha prevalence is expected for the followmg decades, while the percentage of mild patients will contmue to giow Since 1947, when Haldane (15) calculated fitness of haemophihacs to be 0 28, several studies have been published on that subject Accordmg to Francis and Kasper (16) haemophihacs with clottmg activity less than 2% of the normal showed in the penod 1940-1977 a leproduc-tivity late 43% of the expected We found a fitness of 0 62 for Greek haemophiba patients bom aftei 1930 This may leflect impiovement m care m recent peuods Cultuial diffeiences are also impoitant, e g the patient's view concernmg the bnth of daughter carners Lately, a Hungaiian study (17) has reported a fitness of 0 3 for haemophilia A and 0 8 for haemophilia B, which was, however, based on a lelatively small number of patients In The Netherlands fitness for hvmg haemophilia patients was 0 70 (18) , similar to the piesent study if patients who died under 15 would have been excluded Finally, the lower fitness of the younger generations may be explamed by the mfluence ot the HIV in fection m haemophihacs reproductivity aftet 1986, äs well äs by theu delay m the age of marnage (16, 17) Before the mtroduction of Substitution theiapy the cause of deaths among haemophihacs was, almost unvanably, bleedmg The low number of deaths due to all types of bleedmg, except cerebral haemonhage, m this study proves the improvement m the etfectiveness of the provided care Nowadays, haemophihacs aie giowmg older and survive to expenence diseases of the eldeily hke cancer and ischaemic heart disease However, these have not yet become the commonest death causes because of the appearance of transfusion tiansmitted viral diseases Already üom 1975,77% of polytransfused Greek haemophihacs were infected by the hepatitis B virus (12) and 47% had abnormal hver function tests (19) In the present study 8% of deaths weie leported to be caused by hver diseases, givmg cause to the fears expiessed m previous studies (5, 20) Additionally, since haemophihacs infected by HIV, HBV and HCV are not uncommon (21), more deaths due to combmed mfections may be expected for the near future It has been previously reported (20, 22, 23 ) that patients with antibodies have a higher nsk of dymg due to bleedmg than patients without antibodies In this study, however, it seems that this is not the case Suicide was the cause of death for 5% of both Bntish and Dutch haemophihacs (20, 23) , while a high peicentage was also reported from the USA (6) We leport only one suicide of a 34-years-old Schizophrenie patient This may reflect a low suicide täte m the Greek geneial population Cause specific SMRs leveal that no excess mortality due to maiig nancies is observed among Gieek haemophihacs, which is m good agreement with other published studies (6, 20) äs well äs with a recent survey in Dutch haemophihacs for the penod 1986-1992 (unpublished data) Previously a substantial reduction (by 80%) of deaths due to ischaemic heart disease was found in Dutch haemophilia patients (23), which could not be explamed by differences m the presence of major classical nsk factois (24) The conclusion that haemophilia and the lelated clotting defect offei protection agamst ischaemic heart disease is supported by the present lesults m the Greek patients Cerebral hae morrhage accounted for 29% of deaths among HIV(-) patients of this study, which is similai to the figure found m the United Kingdom (20) Among HIV(+) haemophihacs, however, the nsk of fatal cerebral bleedmg appeais to be much higher
The mtention of this study was to estimate the past, leahze the present and plan the futuie, äs well äs to piovtde a baselme foi forthcommg comparative studies m the Greek haemophilia population No more than a decade ago, the mdisputable improvements m haemophilia management would have led similai studies to optimistic predictions However, the shadows of viral mfections peimit at the present only modest expectations, probably combmed with well founded feelmgs of hope
